Maze Therapeutics Inc (MAZE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 196,812 | 0 | 0 | 0 | 29,158 |
| Other current assets | 0 | 0 | 0 | 0 | 4,952 |
| TOTAL | $201,671 | $0 | $0 | $0 | $34,110 |
| Non-Current Assets | |||||
| PPE Net | 6,668 | N/A | N/A | N/A | 22,631 |
| Other Non-Current Assets | 32,203 | 0 | 0 | 0 | 2,410 |
| TOTAL | $38,871 | $N/A | $N/A | $N/A | $25,041 |
| Total Assets | $240,542 | $0 | $0 | $0 | $71,504 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,939 | 0 | 0 | 0 | 2,019 |
| Accrued Expenses | 14,102 | 0 | 0 | 0 | 9,808 |
| TOTAL | $20,673 | $0 | $0 | $0 | $16,316 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 531,052 | 0 | 0 | 0 | 403,982 |
| TOTAL | $531,052 | $N/A | $N/A | $N/A | $403,982 |
| Total Liabilities | $551,725 | $0 | $0 | $0 | $445,352 |
| Shareholders' Equity | |||||
| Common Shares | 2 | 0 | 0 | 0 | 2 |
| Retained earnings | -358,427 | 0 | 0 | 0 | -395,686 |
| TOTAL | $-311,183 | $0 | $0 | $0 | $-373,848 |
| Total Liabilities And Equity | $240,542 | $0 | $0 | $0 | $71,504 |